September 26, 2016 3:33 PM ET

Life Sciences Tools and Services

Company Overview of BIOCOM, Inc.

Company Overview

BIOCOM, Inc. is a life science association. The company focuses on initiatives that influence the region’s life science community in the development and delivery of products, as well as on capital formation, public policy, workforce development, group purchasing, and member services, such as networking events. It represents life sciences communities in Southern California. The company was founded in 1991 and is based in San Diego, California with an additional office in Los Angeles, California.

4510 Executive Drive

Plaza One

San Diego, CA 92121

United States

Founded in 1991

Phone:

858-455-0300

Fax:

858-455-0022

Key Executives for BIOCOM, Inc.

Chief Executive Officer, President and Director
Vice President of Finance
Age: 67
Vice President and General Counsel
Vice President of Public Policy and Communications
Vice President of Business Development
Compensation as of Fiscal Year 2016.

BIOCOM, Inc. Key Developments

Biocom Expands Team in Los Angeles

Biocom announced that its recently-opened Los Angeles office is now fully staffed and operational, advancing on its mission to accelerate life science success in specific and meaningful ways for its members. The new hires bring the Los Angeles office staff total to five. In San Diego, the addition of six new employees represents organic growth at the headquarters office. Biocom's full-time staff across its four offices now stands at 40.

Biocom Appoints Directors to its Board

Biocom announced the appointment of two new directors to its board. David Weitz, Head of Takeda California and Global Research Externalization for parent company Takeda Pharmaceutical Company, Limited, and Wolfgang Glaesner, Ph.D., Chief Scientific Officer at Eli Lilly and Company, were appointed to the board, bringing total board membership to 60. David Weitz, J.D., is the Head of Takeda California and Global Research Externalization for parent company Takeda Pharmaceutical Company Ltd. As the leader of Takeda California, David works to maintain the San Diego site's agile, collaborative and entrepreneurial approach to drug discovery research. As Head of Global Research Externalization, David uses his 24 years of experience in research, business, legal, and intellectual property, as well as a proven track record of alliance formation, to increase the agility of Takeda's Research Division in securing external partnerships and collaborations as a key source of innovation. David began his career as a patent attorney and in 2000 became the first patent attorney to be elected to partnership at Wilson Sonsini Goodrich & Rosati. David joined Syrrx as its General Counsel in 2002. Following Syrrx's acquisition by Takeda in 2005, David has been heavily involved with the integration of Syrrx, Takeda San Francisco and Envoy and numerous business development efforts for Takeda both locally and for the parent company. Dr. Wolfgang Glaesner is Chief Scientific Officer at Lilly in San Diego. Dr. Glaesner first joined Lilly in Indianapolis, working as a protein biochemist in the protein optimization team. In 2009, Dr. Glaesner moved to California to head Lilly's research group. His research interests include the biology of glucagon-like peptide -1, time extension strategies of proteins and peptides, as well as alternative protein scaffolds and their applications in treatment of human disease.

Biocom Announces Board Appointments

Biocom announced the appointment of 13 new directors to its board, including the appointment of Charles Dadswell, senior vice president and general counsel for Illumina, and Rich Pascoe, chief executive officer of Apricus Biosciences, to the executive committee of Biocom's board. In addition, Biocom announced that Magda Marquet, Ph.D., co-founder of Ajinomoto Althea and AltheaDx, and Brent D. Jacobs, executive director in the global life sciences practice group at Cushman & Wakefield, were named as life directors, a prestigious and special class of director. At Illumina, Mr. Dadswell is SVP, general counsel & secretary. He has worldwide responsibility for all legal, government affairs, and intellectual property matters. Before joining Illumina, Mr. Dadswell was vice president, general counsel for North and Latin America and corporate director of global intellectual property at bioMerieux. Mr. Pascoe joined Apricus as CEO in March of 2013 following the merger of Somaxon Pharmaceuticals, where he had served as chief executive officer since August 2008, with Pernix. The additional new members of the board are: Bruno Buisson, Ph.D., founder, general manager and chief scientist, Neuroservice; Peter Callstrom, president and CEO, San Diego Workforce Partnership; Sunita "Sunny" Cooke, Ph.D., superintendent/president, Mira Costa College; Carol Cox, executive vice president, strategy, corporate development and external affairs, NuVasive; J. David Enloe, Jr., president and CEO, Althea; James Mackay, Ph.D., president and chief operating officer, Ardea Biosciences/AstraZeneca; Steven R. Pacelli, executive vice president, strategy and corporate development, Dexcom; Dean Samsvick, partner in charge, Southern California life science practice, KPMG; Stephen Welter, Ph.D., vice president for research and dean of graduate affairs, San Diego State University; Kenneth Weixel, managing partner, San Diego, Deloitte & Touche LLP; Matthew Williams, vice president, state government affairs, AbbVie.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BIOCOM, Inc., please visit www.biocom.org. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.